VNRX VOLITIONRX LTD
Price Chart
Executive Summary
VolitionRx reported full-year 2025 revenue of $1.7M (40% YoY growth) and Q4 revenue growth of 133%, but posted a net loss with EPS of -$0.05, missing consensus of -$0.04. The company highlighted progress in licensing discussions and secured $8.3M in post-year-end funding, though its auditor issued a going concern warning.
Actionable Insight
Despite strong revenue growth and cost reductions, the EPS miss and going concern warning may pressure shares short-term. Monitor the upcoming conference call for clarity on funding runway and licensing deal progress, which could provide upside catalysts.
Key Facts
- Full-year 2025 revenue was $1.7M, up 40% from 2024
- Q4 2025 revenue grew 133% YoY
- Net loss for the year was down 14% vs 2024
- Net cash used in operating activities was $19.7M, down 24%
- Subsequent to year-end, raised $8.3M in non-dilutive and equity funding
- Auditor's opinion includes going concern uncertainty
- EPS of -$0.05 missed consensus of -$0.04 by 25%
Financial Impact
EPS miss of -$0.01 (25% worse than expected) on revenue of $1.7M (40% above prior year)
Risk Factors
- Going concern qualification in auditor's report raises solvency concerns
- Persistent losses and cash burn despite revenue growth
- Reliance on future financing to sustain operations
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001477932-26-001830 |
| Document: vnrx_ex991.htm | 0001477932-26-001830 |
| Document: 0001477932-26-001830-index-headers.html | 0001477932-26-001830 |
| Document: 0001477932-26-001830-index.html | 0001477932-26-001830 |
| Document: 0001477932-26-001830.txt | 0001477932-26-001830 |
| 8-K Data (Synthetic) | 0001477932-26-001830 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
5d ago
|
424B5
| $1.38 awaiting T+5 | awaiting T+5 | — | $1.38 (+0.00%) |
|
Jun 5, 2026
9d ago
|
424B5
| $1.79 awaiting T+5 | awaiting T+5 | — | $1.38 (+22.91%) |
|
May 22, 2026
23d ago
|
8-K
| $2.94 $2.32 | ▲ +21.09% | ▲ +22.30% | $1.38 (+53.06%) |
|
May 14, 2026
4w ago
|
8-K
| $2.00 $3.13 | ▲ +56.50% | ▲ +55.54% | $1.38 (−31.00%) |
|
Apr 30, 2026
6w ago
|
10-K/A
| $2.43 $2.25 | ▼ −7.41% | ▼ −9.75% | $1.38 (−43.21%) |
|
Apr 28, 2026
6w ago
|
8-K
| $2.64 $2.49 | ▼ −5.68% | ▼ −8.79% | $1.38 (−47.73%) |
|
Apr 23, 2026
7w ago
|
8-K
| $2.80 $2.64 | ▲ +5.71% | ▲ +7.19% | $1.38 (+50.71%) |
|
Apr 17, 2026
8w ago
|
8-K
| $3.20 $2.72 | ▼ −14.88% | ▼ −15.79% | $1.38 (−56.88%) |
|
Mar 31, 2026
10w ago
|
8-K
| $4.00 $3.45 | ▼ −13.80% | ▼ −17.57% | $1.38 (−65.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access